Catalyst Repository | Vallon Pharmaceuticals Inc. Common Stock

Vallon Pharmaceuticals Inc. Common Stock

(NASDAQ:VLON)

Description

Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of prescription drugs for central nervous system disorders. The company develops abuse-deterrent amphetamine immediate-release, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder and narcolepsy. It also develops ADMIR, an abuse deterrent formulation of Ritalin. The company was incorporated in 2018 and is based in Philadelphia, Pennsylvania.

VLON Overview

None
Sector
Health Care
Industry
Major Pharmaceuticals

Previous Close
$0.4600
Previous Close Volume
52060